0
     

Report Added
Report already added
G8 Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

G8 Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

The G8 Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: Sector size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the Sector.

Key Highlights

- The G8 countries contributed $6,197.1 billion in 2021 to the global healthcare providers industry, with a compound annual growth rate (CAGR) of 4.4% between 2017 and 2021. The G8 countries are expected to reach a value of $7,838.5 billion in 2026, with a CAGR of 4.8% over the 2021-26 period.
- Among the G8 nations, the US is the leading country in the healthcare providers industry, with market revenues of $4,016.6 billion in 2021. This was followed by Germany and Japan, with a value of $516.2 and $455.0 billion, respectively.
- The US is expected to lead the healthcare providers industry in the G8 nations with a value of $5,288.5 billion in 2016, followed by Germany and Japan with expected values of $617.3 and $494.8 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 healthcare providers Sector
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 healthcare providers Sector
- Leading company profiles reveal details of key healthcare providers Sector players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 healthcare providers Sector with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy

- What was the size of the G8 healthcare providers Sector by value in 2021?
- What will be the size of the G8 healthcare providers Sector in 2026?
- What factors are affecting the strength of competition in the G8 healthcare providers Sector?
- How has the Sector performed over the last five years?
- What are the main segments that make up the G8 healthcare providers Sector?

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Healthcare Providers
2.1. Industry Outlook
3 Healthcare Providers in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Healthcare Providers in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Healthcare Providers in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Healthcare Providers in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Healthcare Providers in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Healthcare Providers in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 Macroeconomic Indicators
14.1. Country data
15 Healthcare Providers in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 Macroeconomic Indicators
16.1. Country data
17 Healthcare Providers in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 Macroeconomic Indicators
18.1. Country data
19 Company Profiles
19.1. Ramsay Health Care Limited
19.2. Fresenius SE & Co. KGaA
19.3. Korian SA
19.4. Mediclinic International Plc
19.5. Spire Healthcare Group Plc
19.6. HCA Healthcare, Inc.
20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 healthcare providers industry, revenue($bn), 2017-26
Table 2: G8 healthcare providers industry, revenue by country ($bn), 2017-21
Table 3: G8 healthcare providers industry forecast, revenue by country ($bn), 2021-26
Table 4: Canada healthcare providers sector value: $ billion, 2017-21
Table 5: Canada healthcare providers sector category segmentation: $ billion, 2021
Table 6: Canada healthcare providers sector geography segmentation: $ billion, 2021
Table 7: Canada healthcare providers sector distribution: % share, by value, 2021
Table 8: Canada healthcare providers sector value forecast: $ billion, 2021-26
Table 9: Canada size of population (million), 2017-21
Table 10: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 11: Canada gdp (current prices, $ billion), 2017-21
Table 12: Canada inflation, 2017-21
Table 13: Canada consumer price index (absolute), 2017-21
Table 14: Canada exchange rate, 2017-21
Table 15: France healthcare providers sector value: $ billion, 2017-21
Table 16: France healthcare providers sector category segmentation: $ billion, 2021
Table 17: France healthcare providers sector geography segmentation: $ billion, 2021
Table 18: France healthcare providers sector distribution: % share, by value, 2021
Table 19: France healthcare providers sector value forecast: $ billion, 2021-26
Table 20: France size of population (million), 2017-21
Table 21: France gdp (constant 2005 prices, $ billion), 2017-21
Table 22: France gdp (current prices, $ billion), 2017-21
Table 23: France inflation, 2017-21
Table 24: France consumer price index (absolute), 2017-21
Table 25: France exchange rate, 2017-21
Table 26: Germany healthcare providers sector value: $ billion, 2017-21
Table 27: Germany healthcare providers sector category segmentation: $ billion, 2021
Table 28: Germany healthcare providers sector geography segmentation: $ billion, 2021
Table 29: Germany healthcare providers sector distribution: % share, by value, 2021
Table 30: Germany healthcare providers sector value forecast: $ billion, 2021-26
Table 31: Germany size of population (million), 2017-21
Table 32: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 33: Germany gdp (current prices, $ billion), 2017-21
Table 34: Germany inflation, 2017-21
Table 35: Germany consumer price index (absolute), 2017-21
Table 36: Germany exchange rate, 2017-21
Table 37: Italy healthcare providers sector value: $ billion, 2017-21
Table 38: Italy healthcare providers sector category segmentation: $ billion, 2021
Table 39: Italy healthcare providers sector geography segmentation: $ billion, 2021
Table 40: Italy healthcare providers sector distribution: % share, by value, 2021
Table 41: Italy healthcare providers sector value forecast: $ billion, 2021-26
Table 42: Italy size of population (million), 2017-21
Table 43: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 44: Italy gdp (current prices, $ billion), 2017-21
Table 45: Italy inflation, 2017-21
Table 46: Italy consumer price index (absolute), 2017-21
Table 47: Italy exchange rate, 2017-21
Table 48: Japan healthcare providers sector value: $ billion, 2017-21
Table 49: Japan healthcare providers sector category segmentation: $ billion, 2021
Table 50: Japan healthcare providers sector geography segmentation: $ billion, 2021
Table 51: Japan healthcare providers sector distribution: % share, by value, 2021
Table 52: Japan healthcare providers sector value forecast: $ billion, 2021-26
Table 53: Japan size of population (million), 2017-21
Table 54: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 55: Japan gdp (current prices, $ billion), 2017-21
Table 56: Japan inflation, 2017-21
Table 57: Japan consumer price index (absolute), 2017-21
Table 58: Japan exchange rate, 2017-21
Table 59: Russia healthcare providers sector value: $ billion, 2017-21
Table 60: Russia healthcare providers sector category segmentation: $ billion, 2021
Table 61: Russia healthcare providers sector geography segmentation: $ billion, 2021
Table 62: Russia healthcare providers sector distribution: % share, by value, 2021
Table 63: Russia healthcare providers sector value forecast: $ billion, 2021-26
Table 64: Russia size of population (million), 2017-21
Table 65: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 66: Russia gdp (current prices, $ billion), 2017-21
Table 67: Russia inflation, 2017-21
Table 68: Russia consumer price index (absolute), 2017-21
Table 69: Russia exchange rate, 2017-21
Table 70: United Kingdom healthcare providers sector value: $ billion, 2017-21
Table 71: United Kingdom healthcare providers sector category segmentation: $ billion, 2021
Table 72: United Kingdom healthcare providers sector geography segmentation: $ billion, 2021
Table 73: United Kingdom healthcare providers sector distribution: % share, by value, 2021
Table 74: United Kingdom healthcare providers sector value forecast: $ billion, 2021-26
Table 75: United Kingdom size of population (million), 2017-21
Table 76: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 77: United Kingdom gdp (current prices, $ billion), 2017-21
Table 78: United Kingdom inflation, 2017-21
Table 79: United Kingdom consumer price index (absolute), 2017-21
Table 80: United Kingdom exchange rate, 2017-21

List of Figures
Figure 1: G8 healthcare providers industry, revenue($bn), 2017-26
Figure 2: G8 Healthcare Providers industry, revenue by country (%), 2021
Figure 3: G8 healthcare providers industry, revenue by country ($bn), 2017-21
Figure 4: G8 healthcare providers industry forecast, revenue by country ($bn), 2021-26
Figure 5: Canada healthcare providers sector value: $ billion, 2017-21
Figure 6: Canada healthcare providers sector category segmentation: % share, by value, 2021
Figure 7: Canada healthcare providers sector geography segmentation: % share, by value, 2021
Figure 8: Canada healthcare providers sector distribution: % share, by value, 2021
Figure 9: Canada healthcare providers sector value forecast: $ billion, 2021-26
Figure 10: Forces driving competition in the healthcare providers sector in Canada, 2021
Figure 11: Drivers of buyer power in the healthcare providers sector in Canada, 2021
Figure 12: Drivers of supplier power in the healthcare providers sector in Canada, 2021
Figure 13: Factors influencing the likelihood of new entrants in the healthcare providers sector in Canada, 2021
Figure 14: Factors influencing the threat of substitutes in the healthcare providers sector in Canada, 2021
Figure 15: Drivers of degree of rivalry in the healthcare providers sector in Canada, 2021
Figure 16: France healthcare providers sector value: $ billion, 2017-21
Figure 17: France healthcare providers sector category segmentation: % share, by value, 2021
Figure 18: France healthcare providers sector geography segmentation: % share, by value, 2021
Figure 19: France healthcare providers sector distribution: % share, by value, 2021
Figure 20: France healthcare providers sector value forecast: $ billion, 2021-26
Figure 21: Forces driving competition in the healthcare providers sector in France, 2021
Figure 22: Drivers of buyer power in the healthcare providers sector in France, 2021
Figure 23: Drivers of supplier power in the healthcare providers sector in France, 2021
Figure 24: Factors influencing the likelihood of new entrants in the healthcare providers sector in France, 2021
Figure 25: Factors influencing the threat of substitutes in the healthcare providers sector in France, 2021
Figure 26: Drivers of degree of rivalry in the healthcare providers sector in France, 2021
Figure 27: Germany healthcare providers sector value: $ billion, 2017-21
Figure 28: Germany healthcare providers sector category segmentation: % share, by value, 2021
Figure 29: Germany healthcare providers sector geography segmentation: % share, by value, 2021
Figure 30: Germany healthcare providers sector distribution: % share, by value, 2021
Figure 31: Germany healthcare providers sector value forecast: $ billion, 2021-26
Figure 32: Forces driving competition in the healthcare providers sector in Germany, 2021
Figure 33: Drivers of buyer power in the healthcare providers sector in Germany, 2021
Figure 34: Drivers of supplier power in the healthcare providers sector in Germany, 2021
Figure 35: Factors influencing the likelihood of new entrants in the healthcare providers sector in Germany, 2021
Figure 36: Factors influencing the threat of substitutes in the healthcare providers sector in Germany, 2021
Figure 37: Drivers of degree of rivalry in the healthcare providers sector in Germany, 2021
Figure 38: Italy healthcare providers sector value: $ billion, 2017-21
Figure 39: Italy healthcare providers sector category segmentation: % share, by value, 2021
Figure 40: Italy healthcare providers sector geography segmentation: % share, by value, 2021
Figure 41: Italy healthcare providers sector distribution: % share, by value, 2021
Figure 42: Italy healthcare providers sector value forecast: $ billion, 2021-26
Figure 43: Forces driving competition in the healthcare providers sector in Italy, 2021
Figure 44: Drivers of buyer power in the healthcare providers sector in Italy, 2021
Figure 45: Drivers of supplier power in the healthcare providers sector in Italy, 2021
Figure 46: Factors influencing the likelihood of new entrants in the healthcare providers sector in Italy, 2021
Figure 47: Factors influencing the threat of substitutes in the healthcare providers sector in Italy, 2021
Figure 48: Drivers of degree of rivalry in the healthcare providers sector in Italy, 2021
Figure 49: Japan healthcare providers sector value: $ billion, 2017-21
Figure 50: Japan healthcare providers sector category segmentation: % share, by value, 2021
Figure 51: Japan healthcare providers sector geography segmentation: % share, by value, 2021
Figure 52: Japan healthcare providers sector distribution: % share, by value, 2021
Figure 53: Japan healthcare providers sector value forecast: $ billion, 2021-26
Figure 54: Forces driving competition in the healthcare providers sector in Japan, 2021
Figure 55: Drivers of buyer power in the healthcare providers sector in Japan, 2021
Figure 56: Drivers of supplier power in the healthcare providers sector in Japan, 2021
Figure 57: Factors influencing the likelihood of new entrants in the healthcare providers sector in Japan, 2021
Figure 58: Factors influencing the threat of substitutes in the healthcare providers sector in Japan, 2021
Figure 59: Drivers of degree of rivalry in the healthcare providers sector in Japan, 2021
Figure 60: Russia healthcare providers sector value: $ billion, 2017-21
Figure 61: Russia healthcare providers sector category segmentation: % share, by value, 2021
Figure 62: Russia healthcare providers sector geography segmentation: % share, by value, 2021
Figure 63: Russia healthcare providers sector distribution: % share, by value, 2021
Figure 64: Russia healthcare providers sector value forecast: $ billion, 2021-26
Figure 65: Forces driving competition in the healthcare providers sector in Russia, 2021
Figure 66: Drivers of buyer power in the healthcare providers sector in Russia, 2021
Figure 67: Drivers of supplier power in the healthcare providers sector in Russia, 2021
Figure 68: Factors influencing the likelihood of new entrants in the healthcare providers sector in Russia, 2021
Figure 69: Factors influencing the threat of substitutes in the healthcare providers sector in Russia, 2021
Figure 70: Drivers of degree of rivalry in the healthcare providers sector in Russia, 2021
Figure 71: United Kingdom healthcare providers sector value: $ billion, 2017-21
Figure 72: United Kingdom healthcare providers sector category segmentation: % share, by value, 2021
Figure 73: United Kingdom healthcare providers sector geography segmentation: % share, by value, 2021
Figure 74: United Kingdom healthcare providers sector distribution: % share, by value, 2021
Figure 75: United Kingdom healthcare providers sector value forecast: $ billion, 2021-26
Figure 76: Forces driving competition in the healthcare providers sector in the United Kingdom, 2021
Figure 77: Drivers of buyer power in the healthcare providers sector in the United Kingdom, 2021
Figure 78: Drivers of supplier power in the healthcare providers sector in the United Kingdom, 2021
Figure 79: Factors influencing the likelihood of new entrants in the healthcare providers sector in the United Kingdom, 2021
Figure 80: Factors influencing the threat of substitutes in the healthcare providers sector in the United Kingdom, 2021

Report Title: G8 Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline